Comments
Loading...

Kura Oncology Analyst Ratings

KURANASDAQ
Logo brought to you by Benzinga Data
$6.43
0.000.00%
At close: -
$6.43
0.000.00%
After Hours: Apr 25, 4:00 PM EDT
Q1 2025 Earnings in 4 days from now on Thu May 1st, after the market close
Conference call scheduled in 4 days at 16:30 PM Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$10.00
Consensus Price Target1
$26.64

Kura Oncology Analyst Ratings and Price Targets | NASDAQ:KURA | Benzinga

Kura Oncology Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Kura Oncology Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
10
Nov 24
1
Dec 24
0
0
0
0
Jan
3
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
HC Wainwright & Co.
JMP Securities
Wedbush
Scotiabank

1calculated from analyst ratings

Analyst Ratings for Kura Oncology

Buy NowGet Alert
03/06/2025Buy Now—UBS
David Dai26%
$27 → $14MaintainsBuyGet Alert
02/27/2025Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$40 → $40ReiteratesBuy → BuyGet Alert
02/06/2025Buy Now—JMP Securities
Reni Benjamin46%
$28 → $28ReiteratesMarket Outperform → Market OutperformGet Alert
02/06/2025Buy Now—Wedbush
Robert Driscoll44%
$34 → $36MaintainsOutperformGet Alert
02/06/2025Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$37 → $40MaintainsBuyGet Alert
01/08/2025Buy Now—Scotiabank
George Farmer42%
$18 → $10MaintainsSector PerformGet Alert
12/09/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—ReiteratesOverweight → OverweightGet Alert
11/26/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—Reiterates → OverweightGet Alert
11/22/2024Buy Now—B of A Securities
Jason Zemansky74%
$36 → $29MaintainsBuyGet Alert
11/21/2024Buy Now—TD Cowen
Phil Nadeau64%
—Reiterates → BuyGet Alert
11/21/2024Buy Now—Jefferies
Roger Song33%
$32 → $28MaintainsBuyGet Alert
11/21/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—Reiterates → OverweightGet Alert
11/21/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $37MaintainsBuyGet Alert
11/19/2024Buy Now—JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
11/18/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
11/06/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—Reiterates → OverweightGet Alert
11/06/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
10/24/2024Buy Now—UBS
David Dai26%
→ $27Initiates → BuyGet Alert
10/24/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
10/14/2024Buy Now—Stifel
Bradley Canino41%
$26 → $19DowngradeBuy → HoldGet Alert
09/09/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—Reiterates → OverweightGet Alert
08/12/2024Buy Now—JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
08/12/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
08/09/2024Buy Now—Cantor Fitzgerald
Li Watsek40%
—Reiterates → OverweightGet Alert
08/09/2024Buy Now—Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
08/09/2024Buy Now—Stifel
Bradley Canino41%
$28 → $26MaintainsBuyGet Alert
06/24/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
06/18/2024Buy Now—JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/16/2024Buy Now—JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/14/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
05/06/2024Buy Now—JMP Securities
Reni Benjamin46%
$32 → $32ReiteratesMarket Outperform → Market OutperformGet Alert
05/03/2024Buy Now—Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
05/03/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
04/22/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
03/06/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now—Stifel
Bradley Canino41%
$27 → $28MaintainsBuyGet Alert
02/28/2024Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
$32 → $32ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now—Wedbush
Robert Driscoll44%
$37 → $37ReiteratesOutperform → OutperformGet Alert
01/31/2024Buy Now—Mizuho
Mara Goldstein57%
$26 → $32MaintainsBuyGet Alert
01/31/2024Buy Now—JMP Securities
Reni Benjamin46%
$22 → $32MaintainsMarket OutperformGet Alert
12/22/2023Buy Now—Mizuho
Mara Goldstein57%
→ $26Initiates → BuyGet Alert
12/08/2023Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
→ $32ReiteratesBuy → BuyGet Alert
11/03/2023Buy Now—Wedbush
Robert Driscoll44%
$40 → $37MaintainsOutperformGet Alert
10/18/2023Buy Now—Wedbush
Robert Driscoll44%
→ $40ReiteratesOutperform → OutperformGet Alert
09/07/2023Buy Now—Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now—B of A Securities
Jason Zemansky74%
→ $31Initiates → BuyGet Alert
08/04/2023Buy Now—Stifel
Bradley Canino41%
$25 → $24MaintainsBuyGet Alert
07/27/2023Buy Now—Scotiabank
George Farmer42%
→ $10.5Initiates → Sector PerformGet Alert
07/21/2023Buy Now—Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
06/13/2023Buy Now—Cantor Fitzgerald
Li Watsek40%
→ $30ReiteratesOverweight → OverweightGet Alert
06/13/2023Buy Now—JMP Securities
Reni Benjamin46%
→ $22ReiteratesMarket Outperform → Market OutperformGet Alert
06/12/2023Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
→ $32ReiteratesBuy → BuyGet Alert
06/12/2023Buy Now—Stifel
Bradley Canino41%
$24 → $25MaintainsBuyGet Alert
05/17/2023Buy Now—BTIG
Justin Zelin41%
→ $31Initiates → BuyGet Alert
05/11/2023Buy Now—Credit Suisse
Tiago Fauth43%
→ $26ReiteratesOutperform → OutperformGet Alert
05/11/2023Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
→ $32ReiteratesBuy → BuyGet Alert
04/17/2023Buy Now—JMP Securities
Reni Benjamin46%
→ $22Reiterates → Market OutperformGet Alert
02/24/2023Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
→ $32Reiterates → BuyGet Alert
02/10/2023Buy Now—HC Wainwright & Co.
Joseph Pantginis45%
→ $32Reiterates → BuyGet Alert
01/31/2023Buy Now—Stifel
Bradley Canino41%
→ $25Initiates → BuyGet Alert
07/13/2022Buy Now—Credit Suisse
Tiago Fauth43%
$27 → $29MaintainsOutperformGet Alert
07/12/2022Buy Now—Cantor Fitzgerald
Li Watsek40%
→ $30Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Kura Oncology (KURA) stock?

A

The latest price target for Kura Oncology (NASDAQ:KURA) was reported by UBS on March 6, 2025. The analyst firm set a price target for $14.00 expecting KURA to rise to within 12 months (a possible 117.73% upside). 34 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Kura Oncology (KURA)?

A

The latest analyst rating for Kura Oncology (NASDAQ:KURA) was provided by UBS, and Kura Oncology maintained their buy rating.

Q

When was the last upgrade for Kura Oncology (KURA)?

A

There is no last upgrade for Kura Oncology

Q

When was the last downgrade for Kura Oncology (KURA)?

A

The last downgrade for Kura Oncology Inc happened on October 14, 2024 when Stifel changed their price target from $26 to $19 for Kura Oncology Inc.

Q

When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.

Q

Is the Analyst Rating Kura Oncology (KURA) correct?

A

While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a maintained with a price target of $27.00 to $14.00. The current price Kura Oncology (KURA) is trading at is $6.43, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch